rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
|
23833300 |
2013 |
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.
|
22649091 |
2012 |
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.
|
21483012 |
2011 |
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Genetic predictors of MEK dependence in non-small cell lung cancer.
|
19010912 |
2008 |
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Mutations of the BRAF gene in human cancer.
|
12068308 |
2002 |
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Missense mutations of the BRAF gene in human lung adenocarcinoma.
|
12460919 |
2002 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
|
23833300 |
2013 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer.
|
23524406 |
2013 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.
|
22743296 |
2012 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.
|
22649091 |
2012 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.
|
22773810 |
2012 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
|
22608338 |
2012 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
The incidence of BRAF mutations other than V600E is significantly higher in lung cancer than in melanoma.
|
21483012 |
2011 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Genetic predictors of MEK dependence in non-small cell lung cancer.
|
19010912 |
2008 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Mutations of the BRAF gene in human cancer.
|
12068308 |
2002 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Missense mutations of the BRAF gene in human lung adenocarcinoma.
|
12460919 |
2002 |
rs1057519719
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
|
23833300 |
2013 |
rs1057519720
|
|
AA |
0.700 |
CausalMutation |
CLINVAR |
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
|
23833300 |
2013 |
rs1057519720
|
|
AA |
0.700 |
CausalMutation |
CLINVAR |
Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib.
|
24035431 |
2013 |
rs121913355
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
|
23833300 |
2013 |
rs121913369
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.
|
23833300 |
2013 |